NOVO NORDISK A S
For the period ended Dec 31, 2023. Filed Jan 31, 2024.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2023 · Filed Jan 31, 2024
Contents
ITEM 16B. CODE OF ETHICS
Novo Nordisk has a vision and a set of essentials named the Novo Nordisk Way. The Novo Nordisk Way describes who Novo Nordisk as a company is, where Novo Nordisk wants to go and how its employees work. The Novo Nordisk Way is principle-based and describes corporate essentials and the required values and mindset of employees on business conduct and ethics including a number of the topics required by the Sarbanes–Oxley Act and the NYSE Listed Company Manual. In addition to the Novo Nordisk Way, a number of guidelines have been established including the launch of OneCode in the fourth quarter of 2023, which serves as a single resource for the principles guiding how Novo Nordisk operates, including business ethics. The Novo Nordisk Way and OneCode apply to all employees in Novo Nordisk including the chief executive officer and chief financial officer, as well as the Board of Directors.
The Novo Nordisk Way and OneCode may be found on our website at novonordisk.com (the contents of the website are not incorporated by reference into this Form 20-F).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.